There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

A Lancet study finds only 40% treatment success for extensively drug-resistant tuberculosis in Europe, with outcomes now ...

LONDON (Thomson Reuters Foundation) - Over the next 35 years, multidrug-resistant tuberculosis will kill 75 million people and could cost the global economy a cumulative $16.7 trillion - the ...

The results of a large, international systematic review show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB). The study was used to inform the ...

An outbreak of multidrug-resistant tuberculosis (TB) developed in Kansas in November 2021, and included multiple children who were born in the U.S. and became infected in the state, CDC researchers ...

For patients with multidrug-resistant tuberculosis (TB), taking at least six potentially effective drugs, particularly including pyrazinamide, significantly increased the likelihood of achieving a ...

An estimated 440 000 cases of multidrug-resistant tuberculosis (MDR TB) occurred worldwide in 2008 (3•6% of all TB cases that year), but only 7% of these cases were identified and treated. Extensively ...

"Multidrug-resistant TB requires complex management decisions, and additional resources will be required to successfully interrupt transmission and cure patients through timely diagnosis, treatment ...

This is a preview. Log in through your library . Abstract Background: Current methodology for multidrug-resistant tuberculosis (MDR TB) surveys endorsed by the World Health Organization provides ...

Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study. These ...